Physician profile
James Dutton
NPI 1831585850
$1,497.46
in general payments reported to CMS, 2019-2025
13 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.27 · 2020: $156 · 2021: $229 · 2022: $28.34 · 2023: $325 · 2024: $542 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $296.92 | 2023-2025 | |
| Davol INC. | $262.04 | 2024 | Arista Ah Flexitip |
| Integra Lifesciences Corporation | $240.62 | 2019-2025 | Integra, Omnigraft, Surgimend |
| Abbvie INC. | $225.05 | 2023-2024 | |
| Baxter Healthcare | $155.56 | 2020-2021 | |
| Stryker Corporation | $145.12 | 2019-2024 | Zip 8i Surgical Skin Closure Device |
| Acell, INC. | $50.06 | 2020 | |
| Tela Bio, INC. | $37.53 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $24.13 | 2025 | Exparel |
| Next Science LLC | $18.41 | 2024 | Surgx, Xperience, Blastx |
| Axogen | $16.16 | 2021 | |
| Merz North America, INC. | $13.25 | 2023 | Xeomin |
| Depuy Synthes Sales INC. | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.